Identification
Instrument name
CARDIO3 BIOSCIENCES
Symbol
CARD
ISIN code
BE0974260896
Exchange / Market
Euronext
Trading location
Brussels
Paris
Products family
Stocks
Market organization
EuronextBrussels
Capitalization compartment
Compartment C
ICB
Biotechnology
Activity description

<p>
Cardio3 BioSciences is a biotechnology company specializing in research and development for regenerative, protective, and reconstructive therapies for treating cardiac disorders (primarily heart failure and myocardial infarction).</p>
<p>
<em>Source: Cofisem</em></p>

Website address
Operation
IPO date
IPO type

<p>
Initial Public Offering</p>

IPO type
Initial Public offering
Catégorie
IPO
Operation calendar

<p>
<strong>Subscription period </strong>:<br />
From 21/06/2013 up to 03/07/2013 &agrave; 16h (Brussels and Paris time)</p>
<p>
<strong>Centralisation date </strong>:<br />
04/07/2013</p>
<p>
<strong>Pricing date / Annoucement of the IPO result :</strong><br />
04/07/2013 / A Euronext market notice will be issued on 04/07/2013</p>
<p>
<strong>First trading date :</strong><br />
The trading will start on 05/07/2013 on an &quot;As-if-andwhen- issued basis&quot; under the product name &quot;CARDIO3 PROMESSES&quot;. The trading of ordinary shares will start on 10/07/2013 under the product name &quot;CARDIO3 BIO&quot; (ISIN code and the trading symbol will remain the same).</p>

Price range
EUR 16.65 - 19.00
Capital raised
23